IMC Reschedules the Final Payment of the Oranim Pharmacy Acquisition
TORONTO and GLIL YAM, Israel, Jan. 12, 2024 /PRNewswire/ — IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the “Company” or “IMC“), a leading medical cannabis company with operations in Israel and Germany, is announcing that the final sixth payment of the Oranim Pharmacy Acquisition and the reconciliation between the parties regarding the remaining transaction payments are being rescheduled to April 15, 2024.
Related news for (IMCC)
- IM Cannabis Signs Non-Binding Term Sheet to Acquire 60% Stake in Innovative Quantum Computing Bio Data Company for Up to $54 Million
- 24/7 Market News Snapshot 23 October, 2025 – IM Cannabis Corp. Common Shares (NASDAQ:IMCC)
- IM Cannabis Announces Board Changes and Strategic Decision to Identify Additional Business Opportunities
- IM Cannabis Regains Compliance with Nasdaq Stockholders’ Equity Listing Requirement
- IM Cannabis Announces Warrant Amendments and Form F-3 Resale Registration Statement Filing
